BILL · 2007–08 SESSION
HB 2123: Antiepileptic drugs
Limiting the interchange of antiepileptic drugs by pharmacists.
Summary
- Provides that a pharmacist may not interchange an antiepileptic drug or formulation of an antiepileptic drug, brand name or generic, for the treatment of seizures without prior notification of and the consent for such interchange from the prescribing physician and patient, or patient's parent, legal guardian, or spouse.
From the Bill Digest (HB 2123), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedFeb 9, 2007
- Out of committeestopped here
- Passed House
- Passed Senate
- Governor
- Law
- Prime sponsor
- Tami Green (D-28)
- Introduced
- February 9, 2007 in the House
- Last action
- January 14, 2008
AN ACT Relating to interchange of antiepileptic drugs by pharmacists;
Sponsors
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health Care & Wellness.
HB 2123 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HB 2123 (2025–26) Foreign nationals/elections
- HB 2123 (2023–24) Running start for the trades
- HB 2123 (2021–22) Cannabinoid products
- HB 2123 (2019–20) MVET collection
- HB 2123 (2017–18) Electrical trainee certific.
- HB 2123 (2015–16) Military tribute bridge
- HB 2123 (2013–14) Transportation/mobility
- HB 2123 (2011–12) Workers' compensation system